1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
The link for this program now points to a previous cycle.
Prior eligibility: Nonprofit research institutions in Washington state for novel products whose intellectual property is owned and managed by the institution.
One-Time Request for Funding: IND-Enabling and Clinical Studies is sponsored by Washington Research Foundation. A specific solicitation for projects supporting late-stage preclinical development and first-in-human clinical trials of therapeutics. This includes gene and cell therapies, as well as small-molecule or protein-based drugs developed at Washington state institutions. Geographic focus: Washington state Focus areas: Therapeutics, Gene Therapy, Cell Therapy, Small-molecule Drugs, Protein-based Drugs, Clinical Trials
The Trump administration is renegotiating $33 billion in CHIPS Act grants, demanding equity stakes in Intel, Samsung, and TSMC. With only 24 of 161 milestones completed and applications still open, here is what the new terms mean for semiconductor manufacturers and supply chain companies.
Read articleThe 2026 UMR economic impact report shows NIH funding produced $94 billion in activity and nearly 400,000 jobs — while success rates hit a 30-year low. The strongest economic argument against cutting biomedical research funding, and what researchers should do now.
Read articleNIST launched a sweeping initiative to standardize how AI agents authenticate, interoperate, and stay secure. Companies building autonomous AI systems need to pay attention now.
Read article